Zymeron
Zymeron: A research-driven biotech firm innovating in healthcare tech for disease detection, prevention, and treatment.
Founded
2016Zymeron: A research-driven biotech firm innovating in healthcare tech for disease detection, prevention, and treatment.
Founded with a mission to revolutionize healthcare technology, Zymeron is a research-driven biotechnology company focused on the discovery, development, and commercialization of innovative solutions for disease detection, prevention, and treatment. The company offers a diverse range of products and services, including precision therapeutics, anti-infective treatments, advanced drug delivery systems, and rapid diagnostic tools. Zymeron's market focus spans across various healthcare sectors, aiming to provide cutting-edge technologies that significantly enhance patient outcomes.
Notable figures associated with Zymeron include leading scientists and industry experts who drive the company's innovation engine. The company has garnered attention from prominent investors in the biotech sector, fueling its growth and research initiatives. Key achievements include the successful development of rapid diagnostic tests and advanced therapeutic formulations that have set new benchmarks in healthcare technology. Zymeron's impact is evident in its contributions to improving disease management and patient care through state-of-the-art biotechnological advancements.
Companies similar to Zymeron include Zenomics, Amplified Sciences, Symic Biomedical and Intellimedix.
Zymeron was founded in 2016.
Zymeron's headquarters is located in Durham, NC, US.
Zymeron's most recent funding round was for $75k (USD) in September 2022.
As of Sep 22, 2022, Zymeron has disclosed funding of $75k (USD). Undisclosed round amounts are excluded.
Zymeron has 13 employees as of Feb 4, 2024.
